Orange Photonics has launched LightLab 3 Psy Analyzer for the measurement of psilocybin, psilocin and 5-AcO-DMT in psychedelic mushrooms, extracts and infused products.
Using High Performance Liquid Chromatography (HPLC), ”the same tech favored by nearly all testing labs,” the new tool aims to support data-driven decisions on strain selection, harvest optimization, extraction, accurate dosing, and safety.
Designed for licensed operators and research institutions and yet reportedly holding a portable, non-technical user type, LightLab was initially developed for cannabis testing applications and now aims to play a pivotal role in cultivation, production and regulatory applications for psychedelics.
See Also: AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
Orange Photonics aims to provide accurate, reliable and innovative analytical testing solutions for several industries. Since 2015, LighLab 3 technology has been used by cannabis operators as well as state and federal regulators, reportedly including the FDA , universities and research institutions.
Orange’s president Stephanie McArdle says LightLab represents the opportunity to incorporate on-site potency analysis into every element of manufacturing and regulation.
"Psychedelics product producers are in a position to ensure consumer safety is a primary focus. LightLab 3 Psy Analyzer is optimized for that critical role," McArdle stated.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
Photo cortesy of Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.